Search filters

List of works by Sabrina Rossi

18F-FDG PET/CT in restaging and evaluation of response to therapy in lung cancer: state of art

scientific article published on 30 December 2019

Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?

scientific article published on 24 March 2017

Are TKIs favourable for the elderly with non-small-cell lung cancer?

scientific article published on 17 May 2016

Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?

scientific article published in April 2018

Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors

scientific article published on 19 February 2020

Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.

scientific article published on 16 August 2017

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

scientific article published on May 2016

DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

scientific article

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

scientific article published on 8 December 2015

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?

scientific article published on 12 March 2018

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis

scientific article published on 27 April 2016

Erratum to: From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

scientific article published on 01 December 2016

From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

scientific article published in December 2016

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

scientific article published on 25 March 2015

Hyper-progressive Disease in Patients With Non-Small Cell Lung Cancer Treated With Checkpoint Inhibitors: The Role of 18F-FDG PET/CT

scientific article published on 20 December 2019

Immunotherapy in non-small-cell lung cancer: potential predictors of response and new strategies to assess activity

scientific article published on 01 July 2018

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors

scientific article published on 02 November 2018

Independent expression of circulating and tissue levels of PD-L1: correlation of clusters with tumor metabolism and outcome in patients with non-small cell lung cancer

scientific article published on 03 September 2019

Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review.

scientific article

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study

scientific article

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

scientific article published on 21 March 2016

Neutrophil and lymphocyte blood count as potential predictive indicators of nivolumab efficacy in metastatic non-small-cell lung cancer

scientific article published on 11 June 2020

Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience

scientific article published on 14 June 2019

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come.

scientific article published on 30 November 2017

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

scientific article published on 22 July 2019

Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy

scientific article published on 15 December 2019

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies.

scientific article published on 8 November 2017

Soluble PD-L1 in NSCLC Patients Treated with Checkpoint Inhibitors and Its Correlation with Metabolic Parameters

scientific article published on 27 May 2020

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer

scientific article published on 11 November 2019

The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors

scientific article published on 11 February 2020

The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'

scientific article published on 21 June 2018

The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art

scientific article published on 05 February 2020

Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

scientific article published on 10 February 2017

Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer

scientific article published on 01 July 2018

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

scientific article published on April 2017

Paulina is supported by:

About Paulina

Help